Its primary mechanism of action involves selectively activating RARs (RAR-β and RAR-γ), which further regulate the expression of downstream induced genes, such as TIG1, TIG2, and TIG3, thereby influencing the proliferation, differentiation, apoptosis, and immune modulation of melanoma cells in the tumor microenvironment. The gene discussed is RARS1; the disease is neoplasm.